 | Up a level |
2022
Striefler, Jana K., Reissig, Timm M., Kunzmann, Volker, Westphalen, C. Benedikt, Boeck, Stefan, Ettrich, Thomas J., Lutz, Manfred P., Waldschmidt, Dirk T., Brunner, Thomas, Uhl, Waldemar, Sinn, Marianne and Siveke, Jens T. (2022). Pancreatic cancer Clinical research projects of the German oncology groups (ACO, AIO, and ARO). Onkologe, 28 (SUPPL 1). S. 30 - 36. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0415
2020
Sinn, Marianne, Sinn, Bruno, V, Treue, Denise, Keilholz, Ulrich, Damm, Frederik, Schmuck, Rosa, Lohneis, Philipp, Klauschen, Frederick, Striefler, Jana K., Bahra, Marcus, Blaeker, Hendrik, Bischoff, Sven, Pelzer, Uwe 
ORCID: 0000-0001-9213-2737, Oettle, Helmut, Riess, Hanno, Budczies, Jan and Denkert, Carsten
(2020).
TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial.
Clin. Cancer Res., 26 (14).
S. 3732 - 3740.
PHILADELPHIA:
AMER ASSOC CANCER RESEARCH.
ISSN 1557-3265
2018
Lohneis, Philipp, Sinn, Marianne, Klein, Fritz, Bischoff, Sven, Striefler, Jana K., Wislocka, Lilianna, Sinn, Bruno V., Pelzer, Uwe ORCID: 0000-0001-9213-2737, Oettle, Helmut, Riess, Hanno, Denkert, Carsten, Blaeker, Hendrik and Juehling, Anja
(2018).
Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma.
Br. J. Cancer, 118 (11).
S. 1485 - 1492.
LONDON:
NATURE PUBLISHING GROUP.
ISSN 1532-1827
2017
Sinn, Marianne, Bahra, Marcus, Liersch, Torsten, Gellert, Klaus, Messmann, Helmut, Bechstein, Wolf ORCID: 0000-0002-3267-8145, Waldschmidt, Dirk, Jacobasch, Lutz, Wilhelm, Martin, Rau, Bettina M., Gruetzmann, Robert, Weinmann, Arndt ORCID: 0000-0003-1198-1716, Maschmeyer, Georg, Pelzer, Uwe ORCID: 0000-0001-9213-2737, Stieler, Jens M., Striefler, Jana K., Ghadimi, Michael, Bischoff, Sven, Doerken, Bernd, Oettle, Helmut and Riess, Hanno
(2017).
CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial.
J. Clin. Oncol., 35 (29).
S. 3330 - 3341.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755